e-learning
resources
Munich 2014
Saturday, 06.09.2014
PG12 The omics revolution: the future of personalised medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Limitations of current clinical diagnosis: phenotype versus endotype
P. J. Sterk (Amsterdam, The Netherlands)
Source:
International Congress 2014 – PG12 The omics revolution: the future of personalised medicine
Session:
PG12 The omics revolution: the future of personalised medicine
Session type:
Postgraduate Course
Number:
117
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. J. Sterk (Amsterdam, The Netherlands). Limitations of current clinical diagnosis: phenotype versus endotype. International Congress 2014 – PG12 The omics revolution: the future of personalised medicine
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Limitations of the current data and clinical perspectives
Source: International Congress 2016 – Is sleep apnoea causing cancer?
Year: 2016
Clinical utility of impulse oscillation system (IOS) for the assessment of clinical status and therapeutic efficacy in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 421s
Year: 2006
Reference values for adults: clinical application and limitations
Source: Annual Congress 2005 - Lung function measurements and predicted values from infants to 100-year-old adults
Year: 2005
Microbiological diagnosis and clinical outcome: where are we?
Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful?
Year: 2008
Change in patients asthma control: Possible bias of transition ratings in clinical practice
Source: Eur Respir J 2003; 22: Suppl. 45, 12s
Year: 2003
Different clinical phenotypes of CLAD: diagnosis and outcomes
Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation
Year: 2015
Challenges in classification of asthma severity from prescription data: a pilot study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019
CPET overview: clinical usefulness and limitations
Source: ERS Skills course - Clinical exercise testing: advanced
Year: 2018
Usefulness of the asthma predictive index in clinical practice: A systematic review and clinical epidemiological analysis
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012
Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort.
Source: International Congress 2017 – Novel and old entities
Year: 2017
Guidelines versus clinical practice in the treatment of COPD: a reappraisal
Source: Eur Respir J 2006; 27: 656
Year: 2006
The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018
Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Patient-ventilator interaction: assessment and clinical relevance
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Thymic neoplasms: clinical presentation, diagnosis and management - A single institution experience
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept